Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Gain Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 25 | 33 | +8 |
| Shares | 1.98M | 2.81M | +827.1K (+41.7%) |
| Value | $3.94M | $5.07M | +$1.12M (+28.5%) |
New holders (10)
Institutions that held Gain Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dauntless Investment Group, LLC | 125,584 | $239.9K | 0.89% |
| Kovitz Investment Group Partners, LLC | 47,578 | $90.9K | 0.00% |
| Quadrature Capital Ltd | 20,154 | $38.3K | 0.00% |
| Two Sigma Securities, LLC | 14,355 | $27.4K | 0.00% |
| Armis Advisers, LLC | 10,750 | $22.0K | 0.00% |
| GWM Advisors LLC | 10,600 | $20.2K | 0.00% |
| Simplex Trading, LLC | 3,444 | $6.00K | 0.00% |
| SRS Capital Advisors, Inc. | 2,500 | $4.78K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,432 | $4.64K | 0.00% |
| FMR LLC | 80 | $154 | 0.00% |
Sold out (2)
Institutions that held Gain Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Royal Bank of Canada | 17,500 | $38.0K |
| Citigroup Inc | 2,000 | $4.32K |